Sen. Warren rips Federal Reserve chair pick Kevin Warsh: 'You have learned nothing from your failures'

Sen. Elizabeth Warren sent an eight-page letter sharply criticizing Kevin Warsh, a Fed governor from 2006-2011 and President Trump's nominee for Fed chair, accusing him of prioritizing Wall Street, defending subprime mortgages, supporting taxpayer-funded bailouts and opposing tougher bank safeguards. Warsh's nomination is effectively stalled: Sen. Thom Tillis says he will block floor consideration pending a criminal probe into Fed Chair Jerome Powell, and Powell has indicated he will remain as chair pro tem if Warsh is not confirmed by May when Powell's chair term expires.

Analysis

The confirmation fight creates a discrete political/regulatory risk premium on large broker-dealers tied to former industry executives; that premium can translate into 20–50bp higher wholesale funding spreads or a mid-single-digit hit to pre-tax earnings for firms with large trading and underwriting footprints. For a bank like MS, which has concentrated investment-banking revenue and capital-markets exposure, a sustained reputational/regulatory shock should compress valuation multiples faster than deposit-funded retail banks because fee pipelines and M&A activity are the first to decelerate.

Second-order industry effects will appear in three channels over different horizons: within days–weeks you get volatility in stock- and CDS-pricing around hearings and court rulings; over 1–3 months you see slowed deal pipelines and larger haircuts on repo funding; over 6–12 months regulatory proposals (or the political threat thereof) push issuers to hoard liquidity and defer buybacks, which mechanically raises equity capital needs. These mechanisms lift short-term term premia and could steepen the curve initially as risk-off buyers favor Treasuries while markets price policy continuity as uncertain.

The consensus is pricing straightforward reputational downside for MS, but this may be overdone if the nomination stalls and Powell remains — continuity would be interpreted as lower policy tail-risk and could rapidly reverse a 10–20% dislocation in financials. Key catalysts to monitor that would flip the trade: (1) judicial rulings on subpoena scope in the next 30–60 days, (2) a public shift from Tillis or other swing senators, and (3) any Fed communication that re-anchors rate path expectations; those three events could compress CDS and unwind a portion of the risk premium within 1–3 weeks of resolution.

Key Decisions for Investors

• Buy MS 3–6 month put spread (buy 1x 15% OTM, sell 1x 10% OTM) to limit premium outlay; thesis: confirmation/legislative noise causes a 10–25% downside in MS equity. Max loss = net premium (~$X), max gain ~3–5x if stock gaps down beyond sold strike. Target holding: until Powell/confirmation clarity (May–Aug 2026).
• Relative-value pair: short MS / long JPM (equal notional) for 3–12 months — short-term regulatory/reputational beta favors underperformance at MS while JPM’s deposit franchise cushions impact. Target spread capture 15–25% with stop-loss if pair divergence narrows >10% intramonth.
• Buy 6–12 month protection on Financials via CDX.NA.FIN (buy protection notional sized to cover equity exposure) — asymmetric hedge: small premium (~mid-single-digit ann. cost) for large spike in credit spreads if regulatory action escalates. Monitor hedge cost vs realized spread for roll decisions.
• Event-driven opportunistic long: if Powell remains and courts rebuff subpoena strategy, initiate a tactical long on XLF sized 1–2% of portfolio for a 2–4 week window — risk: policy continuity already priced; reward: snap-back rally in banks and lower-term premia. Set 7–12% profit trim and 6% stop.